Brain tumor trial: can skipping radiation first save Patients' minds?

NCT ID NCT02444000

Summary

This large, completed trial tested a new treatment order for adults with a rare, aggressive brain tumor. It compared starting with chemotherapy alone versus the standard approach of radiation followed by chemo. The main goal was to see if delaying radiation could better protect patients' memory and thinking skills over time without shortening their lives.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAPLASTIC GLIOMAS WITH 1P/19Q CODELETION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CH Louis Pasteur

    Colmar, 68000, France

  • CHU Bretonneau

    Tours, 37000, France

  • CHU D'Anger

    Angers, 49000, France

  • CHU Sud Réunion

    La Réunion, 97000, France

  • CHU annecy genevois

    Annecy, 74000, France

  • CHU d'Amiens- CHU nord

    Amiens, 80000, France

  • CHU de Bordaux

    Bordeaux, 33000, France

  • CHU de Caen

    Caen, 30000, France

  • CHU de Poitiers

    Poitiers, 86000, France

  • CHU de Rouen

    Rouen, 76000, France

  • CHU la Timone

    Marseille, 13000, France

  • CLCC Eugène Marquis

    Rennes, 44000, France

  • CLCC Institut Gustave Roussy

    Villejuif, 94800, France

  • Centre Hospitalier Perpignan

    Perpignan, 49000, France

  • Centre Hospitalier de Bretagne Sud - Hôpital du Scorff

    Lorient, 56000, France

  • Chu Dupuytren

    Limoges, 87000, France

  • GH Est-Institut d'hématologie et d'oncologie pédiatrique IHOP

    Lyon, 69000, France

  • Groupe Hospitalier Pitié Salpetriere

    Paris, 75013, France

  • HIA du Val de Grâce

    Paris, 75005, France

  • Hopital CLAIRVAL

    Marseille, 13000, France

  • Hopital François Mitterand

    Dijon, 21000, France

  • Hopital Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • Hopital PASTEUR

    Nice, 06000, France

  • Hopital Roger Salengro

    Lille, 59000, France

  • Hopital Saint Louis

    Paris, 75010, France

  • Hopital de la Cavale Blanche

    Brest, 29000, France

  • Hôpital Foch

    Suresnes, 92000, France

  • Hôpital Nord, CHU de Saint-Etienne

    Saint-Etienne, 42000, France

  • Hôpital Pierre Wertheimer

    Lyon, 69000, France

  • ICM, Institut régional du Cancer de Montpellier

    Montpellier, 34000, France

  • IUCT Oncopole - CLCC Institut Claudius Regaud

    Toulouse, 31000, France

  • Institut Pul STRAUSS

    Strasbourg, 67000, France

  • Institut de Cancérologie de l'Ouest (ICO) - site CLCC René Gauducheau

    Nantes, 44000, France

Conditions

Explore the condition pages connected to this study.